Unknown OBSERVATIONAL NCT04481152

Impact of Environmental Exposures on Tumor Risk in Subjects at Risk of Hereditary SDHx Paraganglioma (PGL-EXPO-1)

Impact of Environmental Exposures on Tumor Risk in Subjects at Risk of Hereditary SDHx-related Paragangliomas, Pilot Phase

Sponsor: ANSES

Conditions Environmental Exposure Genetic Predisposition SDH Gene Mutation

Updated 6 times since 2020 Last updated: Jan 17, 2022 Started: Mar 1, 2022 Primary completion: Sep 1, 2022 Completion: Sep 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Environmental Exposure and Genetic Predisposition, this trial is ongoing. The trial is conducted by ANSES and has accumulated 6 data snapshots since 2022. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Feb 2024 — Jul 2024 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Feb 2022 — Feb 2024 [monthly]

Not Yet Recruiting
Jan 2021 — Feb 2022 [monthly]

Not Yet Recruiting

▶ Show 1 earlier version

Aug 2020 — Jan 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ANSES
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.